Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505
about
Mice Lacking the Serotonin Htr2B Receptor Gene Present an Antipsychotic-Sensitive Schizophrenic-Like Phenotype.Chronic upper airway obstruction induces abnormal sleep/wake dynamics in juvenile rats.Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns.Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains.Nesfatin-1/NUCB2 as a potential new element of sleep regulation in rats.Acute Exposure to Pacific Ciguatoxin Reduces Electroencephalogram Activity and Disrupts Neurotransmitter Metabolic Pathways in Motor Cortex.Differential adaptation of REM sleep latency, intermediate stage and theta power effects of escitalopram after chronic treatment.Acute escitalopram treatment inhibits REM sleep rebound and activation of MCH-expressing neurons in the lateral hypothalamus after long term selective REM sleep deprivation.Chronic escitalopram treatment caused dissociative adaptation in serotonin (5-HT) 2C receptor antagonist-induced effects in REM sleep, wake and theta wave activity.Coupling changes in cortical and pontine sigma and theta frequency oscillations following monoaminergic lesions in rat.Effect of Olanzapine on Clinical and Polysomnography Profiles in Patients with Schizophrenia.
P2860
Q30371206-5774B8C4-8DFD-4D07-9D1C-5462420B15D6Q30438419-C2C5AD15-75DB-43F5-9F03-551E55D3568FQ34144175-0DAE1353-4203-455E-803C-6C033BEBDFC1Q34568610-38B2CB26-976D-4D49-A7EC-E625C106364EQ34656235-F4104EAB-073D-4184-900F-615B7AD3055BQ36129018-A9D6A4DB-1BDC-4246-8ED2-64D2E1903253Q45251058-187482F6-A30F-4E8B-B08E-421FEB23AC45Q48117353-5196F8EA-A4F4-40B9-B00B-F4951B5CC9B4Q48133366-7A2C3757-1597-4B83-9BCD-07199DCE0B3DQ48318501-63019B8F-2A01-4A67-850F-AED32E0FF919Q55305976-CDD172B9-7B5C-4E39-AF91-5F871CE37D2F
P2860
Increased wakefulness, motor activity and decreased theta activity after blockade of the 5-HT2B receptor by the subtype-selective antagonist SB-215505
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Increased wakefulness, motor a ...... selective antagonist SB-215505
@ast
Increased wakefulness, motor a ...... selective antagonist SB-215505
@en
Increased wakefulness, motor a ...... selective antagonist SB-215505
@nl
type
label
Increased wakefulness, motor a ...... selective antagonist SB-215505
@ast
Increased wakefulness, motor a ...... selective antagonist SB-215505
@en
Increased wakefulness, motor a ...... selective antagonist SB-215505
@nl
prefLabel
Increased wakefulness, motor a ...... selective antagonist SB-215505
@ast
Increased wakefulness, motor a ...... selective antagonist SB-215505
@en
Increased wakefulness, motor a ...... selective antagonist SB-215505
@nl
P2093
P2860
P356
P1476
Increased wakefulness, motor a ...... selective antagonist SB-215505
@en
P2093
Anita Benko
Brigitta Balogh
Rita Jakus
Sandor Kantor
P2860
P304
P356
10.1038/SJ.BJP.0705887
P407
P50
P577
2004-08-01T00:00:00Z